A health care worker sprays disinfectant outside a USAID, funded Ebola clinic in Monrovia, Liberia, Friday, Jan. 30, 2015. (AP Photo/ Abbas Dulleh)
Your feedback is important to us!
We invite all our readers to share with us their views and comments about this article.
Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.
Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (http://bit.ly/vDisqus)
Liberia began a trial of experimental Ebola vaccines on Monday, involving thousands of volunteers as part of an effort to slow the spread of the deadly haemorrhagic fever and prevent future outbreaks.Its spread now appears to be slowing, especially in Liberia which has reported just 15 new cases in the past 21 days.Liberia's Deputy Health Minister Tolbert Nyenswah said he did not expect the vaccines to make a difference in the current outbreak.Given relatively few new cases in the dwindling outbreak, researchers are concerned the trial in Liberia, plus another planned in Sierra Leone, may not have the statistical power needed to show whether the shots work.Chimerix Inc said on Friday it was stopping participation in clinical studies in Liberia of a drug, brincidofovir, to treat people who already have Ebola, citing the slump in new cases.
FOLLOW THIS ARTICLE